These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33423655)

  • 1. Poloxamer Modified Chitosan Nanoparticles for Vaginal Delivery of Acyclovir.
    Deshkar S; Sikchi S; Thakre A; Kale R
    Pharm Nanotechnol; 2021; 9(2):141-156. PubMed ID: 33423655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 3. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
    Aljaeid BM; El-Say KM; Hosny KM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
    [No Abstract]   [Full Text] [Related]  

  • 4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
    Patel PJ; Gohel MC; Acharya SR
    Pharm Dev Technol; 2014 Mar; 19(2):200-12. PubMed ID: 23432525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
    Abd-Elsalam WH; Ibrahim RR
    Int J Pharm; 2021 Nov; 609():121214. PubMed ID: 34678396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
    Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
    Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of chitosan nanoparticles loaded nanofiber hybrid system for vaginal controlled release of benzydamine.
    Tuğcu-Demiröz F; Saar S; Kara AA; Yıldız A; Tunçel E; Acartürk F
    Eur J Pharm Sci; 2021 Jun; 161():105801. PubMed ID: 33691155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
    Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
    Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
    Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
    Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Nanoparticles of Gamma-Oryzanol: Formulation, Optimization, and In vivo Evaluation of Anti-hyperlipidemic Activity.
    Rawal T; Mishra N; Jha A; Bhatt A; Tyagi RK; Panchal S; Butani S
    AAPS PharmSciTech; 2018 May; 19(4):1894-1907. PubMed ID: 29663289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
    Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
    Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of N,O-Carboxymethyated chitosan and its application in the development of acyclovir loaded nanoparticles.
    Adnan S; Ranjha NM; Hanif M
    Pak J Pharm Sci; 2019 Sep; 32(5(Supplementary)):2261-2267. PubMed ID: 31894053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin functionalized poloxamer-chitosan nanoparticles of metformin: physicochemical characterization,
    Birajdar SV; Mazahir F; Yadav AK
    Drug Dev Ind Pharm; 2023 Dec; 49(12):734-747. PubMed ID: 37982183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
    Gupta M; Marwaha RK; Dureja H
    Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.
    Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD
    Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pluronic F-68 vs Tween 80 on Fabrication and Evaluation of Acyclovir SLNs for Skin Delivery.
    Bhupinder K; Newton MJ
    Recent Pat Drug Deliv Formul; 2016; 10(3):207-221. PubMed ID: 27456458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
    Zhang WL; Liu JP; Liu XX; Chen ZQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.